These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Relative antiplasmin (antifibrinolysin) activity of omega-aminocarboxylic acids. MIYAMOTO M; LEE KH J Pharm Sci; 1962 Sep; 51():912-3. PubMed ID: 14474810 [No Abstract] [Full Text] [Related]
24. [STUDIES ON TRYPSIN INHIBITOR AND ANTIPLASMIN IN HUMAN SERUM. II. ON VARIOUS DISEASES EXCEPT ARTERIOSCLEROSIS]. MATSUDA T Nihon Ketsueki Gakkai Zasshi; 1963 Oct; 26():590-7. PubMed ID: 14098708 [No Abstract] [Full Text] [Related]
25. Synthesis of active center-directed peptide inhibitors of plasmin. Okada Y; Tsuda Y; Teno N; Wanaka K; Bohgaki M; Hijikata-Okunomiya A; Naito T; Okamoto S Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1289-97. PubMed ID: 2970896 [No Abstract] [Full Text] [Related]
26. Haemophilia and the protease inhibitor in peanuts. ASTRUP T; BRAKMAN P; SJOLIN KE Nature; 1962 Jun; 194():980-1. PubMed ID: 13863030 [No Abstract] [Full Text] [Related]
28. Studies on the mechanism of action of synthetic antifibrinolytics. A comparison with the action of derivatives of benzamidine on the fibrinolytic process. Landmann H Thromb Diath Haemorrh; 1973 May; 29(2):253-75. PubMed ID: 4271586 [No Abstract] [Full Text] [Related]
29. [Action of an amino acid complex on experimental atherogenesis in the rabbit]. RULLI V Boll Soc Ital Biol Sper; 1962 Mar; 38():201-4. PubMed ID: 14495247 [No Abstract] [Full Text] [Related]
30. Plasminogen-plasmin system. VII. Potentiation of antifibrinolytic action of a synthetic inhibitor, tranexamic acid, by alpha 2-macroglobulin antiplasmin. Abiko Y; Iwamoto M Biochim Biophys Acta; 1970 Sep; 214(3):411-8. PubMed ID: 4251764 [No Abstract] [Full Text] [Related]
31. [SIGNIFICANCE OF FIBRINOLYSIS IN EXPERIMENTAL ATHEROGENESIS DUE TO HYPERCHOLESTEROLIC DIET. II. EFFECTS OF A SULFO-POLYSACCHARIDE OF LOW MOLECULAR WEIGHT]. BORGATTI E; GENNARI P; LORETI A; MAVRULIS A; COCCHERI S G Clin Med; 1964 Dec; 45():1453-65. PubMed ID: 14320254 [No Abstract] [Full Text] [Related]
32. [Possibilities of the method of fibrin plates for determination of the activity of the blood fibrinolytic system components]. Butorov VN; Bokarev IN Lab Delo; 1978; (5):271-3. PubMed ID: 79009 [No Abstract] [Full Text] [Related]
33. [Some biochemical indices of the blood under the effect of fibrinolysin in rabbits with experimental cholesterol atherosclerosis]. Kirpanev OV Patol Fiziol Eksp Ter; 1967; 11(2):67-8. PubMed ID: 4241591 [No Abstract] [Full Text] [Related]
34. [The function of naturally fibrinolysis inhibiting agents in normal plasma and normal thrombocytes]. den Ottolander GJ; Leijnse B; Cremer-Elferink MM Ned Tijdschr Geneeskd; 1968 May; 112(19):920-1. PubMed ID: 4233299 [No Abstract] [Full Text] [Related]
35. The biochemistry of the fibrinolytic enzyme system in man. Rickli EE Angiologica; 1968; 5(2):66-79. PubMed ID: 4232516 [No Abstract] [Full Text] [Related]
36. Trinitrophenyl-derivative of urinary trypsin inhibitor: a strong antifibrinolytic agent. Sumi H; Hamada H; Maehara S; Yoshida E; Tsushima H; Maruyama M; Mihara H Acta Haematol; 1987; 78(4):225-8. PubMed ID: 2962413 [TBL] [Abstract][Full Text] [Related]
37. ATHEROGENESIS IN RABBITS FED SIMULATED HUMAN DIET. BECKEL F Arch Pathol; 1964 Jun; 77():563-7. PubMed ID: 14130040 [No Abstract] [Full Text] [Related]